false

Jim Watson

Pharmaceutical industry veteran with extensive experience in high-purity utilities, large molecule biological processes and advanced therapies. Expert in early-phase manufacturing strategy, conceptual design, user requirement specifications, verification, validation, facility turnover, and facility operations. Trusted lead on operational and commercial readiness programs. Leader on the cell and gene therapy task force.

• Read: When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?

  Manufacturing

  When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?

  Apr 24, ‘24 | 1 min read

  • 

    Anshul M.

  • 

    Jim W.

  Discover

Loading...

You've reach the end Back to top